| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |